COVID-19 and Acute Heart Failure: Screening the Critically Ill - A Position Statement of the Cardiac Society of Australia and New Zealand (CSANZ).
Australia
/ epidemiology
Betacoronavirus
COVID-19
Cardiology
/ methods
Consensus
Coronavirus Infections
/ epidemiology
Critical Illness
/ therapy
Heart Failure
/ diagnosis
Humans
Infection Control
/ methods
Myocarditis
/ complications
New Zealand
/ epidemiology
Pandemics
/ prevention & control
Patient Care Management
/ methods
Pneumonia, Viral
/ epidemiology
Risk Adjustment
/ methods
SARS-CoV-2
Societies, Medical
Acute cardiomyopathy
COVID-19
High sensitivity troponin
Myocarditis
Screening algorithm
Targeted transthoracic echocardiogram
Journal
Heart, lung & circulation
ISSN: 1444-2892
Titre abrégé: Heart Lung Circ
Pays: Australia
ID NLM: 100963739
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
pubmed:
19
5
2020
medline:
19
8
2020
entrez:
19
5
2020
Statut:
ppublish
Résumé
Up to one-third of COVID-19 patients admitted to intensive care develop an acute cardiomyopathy, which may represent myocarditis or stress cardiomyopathy. Further, while mortality in older patients with COVID-19 appears related to multi-organ failure complicating acute respiratory distress syndrome (ARDS), the cause of death in younger patients may be related to acute heart failure. Cardiac involvement needs to be considered early on in critically ill COVID-19 patients, and even after the acute respiratory phase is passing. This Statement presents a screening algorithm to better identify COVID-19 patients at risk for severe heart failure and circulatory collapse, while balancing the need to protect health care workers and preserve personal protective equipment (PPE). The significance of serum troponin levels and the role of telemetry and targeted transthoracic echocardiography (TTE) in patient investigation and management are addressed, as are fundamental considerations in the management of acute heart failure in COVID-19 patients.
Identifiants
pubmed: 32418875
pii: S1443-9506(20)30133-5
doi: 10.1016/j.hlc.2020.04.005
pmc: PMC7252099
pii:
doi:
Types de publication
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
e94-e98Informations de copyright
Copyright © 2020 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.
Références
Heart Lung Circ. 2020 Jun;29(6):e78-e83
pubmed: 32467031
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
JAMA Cardiol. 2020 Jul 1;5(7):751-753
pubmed: 32219362
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
Eur Heart J. 2021 Jan 7;42(2):206
pubmed: 32176300
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
JAMA Cardiol. 2020 Jul 1;5(7):819-824
pubmed: 32219357
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
JAMA. 2020 Apr 28;323(16):1612-1614
pubmed: 32191259
Circulation. 2020 Feb 11;141(6):e69-e92
pubmed: 31902242
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Med J Aust. 2020 Jun;212(10):472-481
pubmed: 32356900